Table 2.
Comparisons between CaD treatment and control treatment groups in UAER changes from baseline.
| Number of studies | Number of subjects (CaD versus control) | WMD from baseline | 95% CI | I 2 | |
|---|---|---|---|---|---|
| All | 7 | 220/216 | −43.73∗ | −52.63, −34.82 | 92% |
| Monotherapy | 3 | 88/84 | −52.08∗ | −59.21, −44.96 | 63% |
| Combination with ACEI/ARB treatment | 4 | 132/132 | −37.26∗ | −49.03, −25.48 | 92% |
∗ P < 0.001.